1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Wound Care Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising geriatric population and high prevalence of diabetes
5.1.1.2. Significant growth in numbers of burn injuries and road accidents worldwide
5.1.1.3. Government initiatives regarding wound care treatment
5.1.2. Restraints
5.1.2.1. High cost associated with advanced wound care and incidences of product recall
5.1.3. Opportunities
5.1.3.1. Development of novel biomaterials with superior mechanical properties and customizable degradation profiles
5.1.3.2. Inclination toward cost effective wound care coupled with positive investments in wound care management
5.1.4. Challenges
5.1.4.1. Limited availability of skilled professionals and contamination issues in wound care
5.2. Market Segmentation Analysis
5.2.1. Product: Significant penetration of advanced wound dressings to promote adequate wound healing
5.2.2. Devices: High adoption of negative pressure wound therapy systems
5.2.3. Offering Type: Prescribed wound care options cater to complex medical conditions with tailored clinical interventions
5.2.4. Application: Proliferating utilization of wound care solutions in acute wounds
5.2.5. End User: Specialty clinics having a specialized focus on complex wound care
5.3. Market Trend Analysis
5.3.1. Significant emphasis on securing product approval and improving efficacy of wound care solutions in the Americas
5.3.2. Rising burn incidences and breakthroughs in wound care solutions in the APAC region
5.3.3. Expanding wound care facilities to treat chronic and acute injuries in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Wound Care Market, by Product
6.1. Introduction
6.2. Advanced Wound Dressing
6.3.1. Alginate Dressings
6.3.2. Collagen Dressings
6.3.3. Film Dressings
6.3.4. Foam Dressings
6.3.5. Hydrocolloid Dressings
6.3.6. Hydrogel Dressings
6.3. Surgical Wound Care
6.4.1. Anti-Infective Dressing
6.4.2. Sutures & Staples
6.4.3. Tissue Adhesive & Sealants
6.4. Traditional Wound Care Products
6.5.1. Bandages
6.5.2. Cleansing Agents
6.5.3. Cotton
6.5.4. Gauzes
6.5.5. Medical Tapes
6.5.6. Sponges
7. Wound Care Market, by Devices
7.1. Introduction
7.2. Electric Stimulation Devices
7.3. Hyperbaric Oxygen Equipment
7.4. Negative Pressure Wound Therapy Systems
7.5. Oxygen & Hyperbaric Oxygen Equipment
7.6. Pressure Relief Devices
8. Wound Care Market, by Offering Type
8.1. Introduction
8.2. Non-prescribed (OTC)
8.3. Prescribed
9. Wound Care Market, by Application
9.1. Introduction
9.2. Acute Wounds
9.3.1. Burn Wounds
9.3.2. Surgical & Traumatic Wounds
9.3. Chronic Wounds
9.4.1. Diabetic Foot Ulcers
9.4.2. Pressure Ulcers
9.4.3. Venous Leg Ulcers
10. Wound Care Market, by End User
10.1. Introduction
10.2. Home Healthcare
10.3. Hospitals
10.4. Specialty Clinics
10.5. Trauma Centers
11. Americas Wound Care Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Wound Care Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Wound Care Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Merger & Acquisition
14.3.1.1. Coloplast Expands Wound Care Offerings with Kerecis Acquisition
14.3.1.2. LifeNet Health Acquires Best-In-Class Wound Care Portfolio
14.3.1.3. Argentum Medical Acquires Anacapa Technologies
14.3.2. Agreement, Collaboration, & Partnership
14.3.2.1. MediWound Announces Collaboration with 3M on EscharEx Phase III StudyMediWound to Join Forces with 3M Health Care
14.3.2.2. Smith+Nephew receives Innovative Technology contract from Vizient for PICO Single Use Negative Pressure Wound Therapy Systems
14.3.2.3. Evonik Cooperates with Coopmed for Distribution Of Wound Dressing Epicite
14.3.3. New Product Launch & Enhancement
14.3.3.1. Medela To Launch New Invia Integrated Dressing For Wounds
14.3.3.2. Evonik Company JeNaCell Launches Wound Dressing Epicite Balance For Chronic Wounds
14.3.3.3. Healthium Medtech Launches New Wound Dressing Portfolio
14.3.4. Investment & Funding
14.3.4.1. Mimix Biotherapeutics’ Breakthrough Tissue Regeneration Treatment Receives Strategic Investment
14.3.4.2. SolasCure Raises EUR 12M in Series B finance
14.3.5. Award, Recognition, & Expansion
14.3.5.1. 3M Veraflo Therapy Dressings Receive First-Ever FDA Clearance For Hydromechanical Removal Of Non-Viable Tissue
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. 3M Company
15.1.2. Advanced Medical Solutions Group PLC
15.1.3. Advancis Medical
15.1.4. Argentum Medical, LLC
15.1.5. AVERY DENNISON CORPORATION
15.1.6. Axio Biosolutions Pvt. Ltd.
15.1.7. Azelis Group
15.1.8. B. Braun SE
15.1.9. Baxter International Inc.
15.1.10. Bayer AG
15.1.11. Becton, Dickinson and Company
15.1.12. Cardinal Health, Inc.
15.1.13. Coloplast A/S
15.1.14. Convatec Limited
15.1.15. Cypress Medical Products LLC
15.1.16. Essity AB
15.1.17. Gentell
15.1.18. Globus Medical, Inc.
15.1.19. H&H Medical Corporation by Safeguard Medical Holdco, LLC
15.1.20. Healthium Medtech Limited
15.1.21. Hollister Incorporated
15.1.22. Integra LifeSciences Corporation
15.1.23. Invacare Corporation
15.1.24. JeNaCell by Evonik Industries AG
15.1.25. Johnson & Johnson Services, Inc.
15.1.26. Lohmann & Rauscher GmbH & Co. KG
15.1.27. Medela AG
15.1.28. Medline Industries, LP
15.1.29. Medtronic PLC
15.1.30. Mölnlycke Health Care AB
15.1.31. Novo Nordisk A/S
15.1.32. PAUL HARTMANN AG
15.1.33. Smith & Nephew PLC
15.1.34. Stryker Corporation
15.1.35. Talley Group Ltd.
15.1.36. Welcare Industries S.p.A
15.1.37. Winner Medical Co., Ltd.
15.1.38. WoundEL Health Care
15.1.39. Zimmer Biomet
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
